[1]鲍静,周琼.早期阿尔茨海默病患者黄斑区视网膜血管密度及厚度变化——基于OCTA的测量[J].眼科新进展,2020,40(6):547-550.[doi:10.13389/j.cnki.rao.2020.0125]
 BAO Jing,ZHOU Qiong.Changes of retinal blood vessel density and thickness in macular area of patients with early Alzheimer’s disease by OCTA detection[J].Recent Advances in Ophthalmology,2020,40(6):547-550.[doi:10.13389/j.cnki.rao.2020.0125]
点击复制

早期阿尔茨海默病患者黄斑区视网膜血管密度及厚度变化——基于OCTA的测量/HTML
分享到:

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
40卷
期数:
2020年6期
页码:
547-550
栏目:
应用研究
出版日期:
2020-06-05

文章信息/Info

Title:
Changes of retinal blood vessel density and thickness in macular area of patients with early Alzheimer’s disease by OCTA detection
作者:
鲍静周琼
330006 江西省南昌市,南昌大学第一附属医院眼科
Author(s):
BAO JingZHOU Qiong
Department of Ophthalmology,the First Affiliated Hospital of Nanchang University,Nanchang 330006,Jiangxi Province,China
关键词:
阿尔茨海默病黄斑区厚度光学相干断层扫描血管成像黄斑区血管密度
Keywords:
Alzheimer’s disease thickness of macular area optical coherence tomography scanning angiography vascular density in macular area
分类号:
R774
DOI:
10.13389/j.cnki.rao.2020.0125
文献标志码:
A
摘要:
目的 利用光学相干断层扫描血管成像(OCTA)评估早期阿尔茨海默病(AD)患者黄斑区视网膜血管密度和视网膜厚度变化。方法 临床检查确诊的轻度AD患者16例32眼(AD组)纳入本研究,正常对照组选取性别、年龄相匹配16例32眼。两组受检者性别构成比、年龄、眼压差异均无统计学意义(均为P>0.05)。所有受检眼均行高清OCTA检查,以黄斑中心为圆心,直径为3.0 mm的快速扫描,获取黄斑区视网膜上方、下方、颞侧、鼻侧4个象限血管密度及其厚度。比较两组受检眼之间不同眼别的黄斑区视网膜厚度及视网膜血管密度变化。结果 两组受检者智力状况检查法(mini-mental state examination,MMSE)评分及视力差异均有统计学意义(均为P<0.05)。与正常对照组相比,AD组患者双眼黄斑区厚度、中心凹视网膜厚度变薄,差异均有统计学意义(均为P<0.05);AD组患者黄斑区视网膜血管密度在整体、中心凹、旁中心凹、颞侧及上方均显著降低(均为P<0.05),且左右眼具有一致性。AD组患者黄斑区鼻侧及下方平均血管密度较正常对照组降低,但差异均无统计学意义(均为P>0.05)。AD组、正常对照组受检者两眼之间黄斑区视网膜血管密度差异均无统计学意义(均为P>0.05)。结论 早期AD患者可发生黄斑区视网膜厚度变薄、黄斑区血管密度降低的退行性视网膜病变,而OCTA可为AD早期诊断、随访、评估疗效提供一定的参考价值。
Abstract:
Objective To evaluate changes in macular retinal blood vessel density and retinal thickness macular area for patients with early Alzheimer’s disease (AD) by optical coherence tomography (OCTA). Methods Sixteen patients (32 eyes) with mild AD confirmed by clinical examination were included in the study (AD group). In the normal control group, 16 patients with 32 eyes were selected who were matched in gender and age. There was no statistical significance in gender composition ratio, age or intraocular pressure of the subjects between the two groups (all P>0.05). All eyes were examined with high-definition OCTA. Rapid scanning with the macular center as the center and the diameter of 3.0 mm was used to obtain the blood vessel density and thickness in the four quadrants (above, below, temporal and nasal sides) of the macular area. The changes of retinal thickness and retinal blood vessel density in macular area were compared between the two groups. Results There was statistical significances in mini-mental state examination (MMSE) score and visual acuity in AD group and normal control group (both P<0.05). Compared with the normal control group, the average thickness of macular area and the thickness of fovea retina decreased in the AD group, with statistically significant differences (all P<0.05). In the AD group, the retinal blood density in macular area was significantly reduced in the whole, fovea, para-fovea, temporal side and upper part (all P<0.05), and the consistency was found in the left and right eyes. In addition, the average blood flow density on the nasal side and the lower part of the macular area in the AD group was lower than that in the normal control group, but the difference was not statistically significant (all P>0.05). There was no statistically significant difference in retinal blood vessel density density between both eyes of subjects in AD group and normal control group (both P>0.05). Conclusion Patients with early AD may develop degenerative retinopathy with thinning retinal thickness in macular area and decreased blood vessel density in macular area. OCTA technology can provide reference value for early diagnosis, follow-up and evaluation of the efficacy of AD.

参考文献/References:

[1] GINTER E,SIMKO V,WEINREBOVA D,LADECKA Z.Novel potential for the management of Alzheimer disease[J].Bratisl Lek Listy,2015,116(10):580-581.
[2] The Lancet Neurology.Alzheimer’s disease:a time for cautious optimism [J].Lancet Neurol,2015,14(8):779.
[3] ALBRAHIM T.The potential role of nutritional components in improving brain function among patients with Alzheimers disease:a meta-analysis of RCT studies [J].Neurosciences (Riyadh),2020,25(1):4-17.
[4] PABLO P D,MONLLOR B,MONCHO V,DOLORES D F.Visual function alterations in Alzheimer disease:A case report [J].Can J Ophthalmol,2016,51(1):e16-18.
[5] POLO V,RODRIGO M J,GARCIA-MARTIN E,OTIN S,LARROSA J M,FUERTES M I,et al.Visual dysfunction and its correlation with retinal changes in patients with Alzheimer’s disease [J].Eye (Lond),2017,31(7):1034-1041.
[6] BAMBO M P,GARCIA-MARTIN E,GUTIERREZ-RUIZ F,PINILLA J,PEREZ-OLIVAN S,LARROSA J M,et al.Analysis of optic disk color changes in Alzheimer’s disease:a potential new biomarker [J].Clin Neurol Neurosurg,2015,132:68-73.
[7] OH J,BAIK D J,AHN J.Inter-relationship between retinal and choroidal vasculatures using optical coherence tomography angiography in normal eyes [J].Eur J Ophthalmol,2020,30(1):48-57.
[8] SNYDER H M,KIM H,BAIN L J,EGGE R,CARRILLO M C.Alzheimer’s disease public-private partnerships:update 2014 [J] .Alzheimers Dement,2014,10(6):873-880.
[9] BERISHA F,FEKE G T,TREMPE C L,MCMEEL J W,SCHEPENS C L.Retinal abnormalities in early Alzheimer’s disease [J].Invest Ophthalmol Visual Sci,2007,48(5):2285-2289.
[10] VEVERKA K K,ABOUCHEHADE J E,IEZZI R,PULIDO J S.Noninvasive Grading of Radiation Retinopathy:The use of optical coherence tomography angiography [J].Retina,2015,35(11):2400-2410.
[11] ERSKINE L,HERRERA E.Connecting the retina to the brain [J].ASN Neuro,2014,6(6):pii1759091414562107.
[12] SEIL Y,ARC,NCESU T K,GRGR N,BECKMANN Y,ERTEKIN C.Dysphagia in Alzheimer’s disease [J].Neurophysiol Clin,2016,46(3):171-178.
[13] DELRIEU J,OUSSET P J,VOISIN T,VELLAS B.Amyloid beta peptide immunotherapy in Alzheimer disease [J].Rev Neurol,2014,170(12):739-748.
[14] YAVARPOUR-BALI H,GHASEMI-KASMAN M,SHOJAEI A.Direct reprogramming of terminally differentiated cells into neurons:A novel and promising strategy for Alzheimer’s disease treatment [J].Prog Neuropsychopharmacol Biol Psychiat,2020,98:109820.
[15] BIGOT C,VANHOUTTE G,VERHOYE M,LINDEN A V D.Magnetization transfer contrast imaging reveals amyloid pathology in Alzheimer’s disease transgenic mice [J].Neuroimage,2014,87:111-119.
[16] AGUZZI A.Neurodegeneration:Alzheimer’s disease under strain [J].Nature,2014,512(7512):32-34.
[17] KLOOS M,WEIGEL S,LUKSCH H.Anatomy and physiology of neurons in layer 9 of the chicken optic tectum [J].Front Neural Circuits,2019,13:63.
[18] MURCIA-BELMONTE V,ERSKINE L.Wiring the binocular visual pathways[J].Int J Mol Sci,2019,20(13): pii:E3282.
[19] SALAZAR-GONZALEZ A,KABA D,LI Y,LIU X.Segmentation of the blood vessels and optic disk in retinal images[J].IEEE J Biomed Health Inform,2014,18(6):1874-1886.
[20] JINDAL V.Interconnection between brain and retinal neurodegenerations [J].Mol Neurobiol,2015,51(3):885-892.
[21] JUNG N Y,HAN J C,ONG Y T,CHEUNG C Y,CHEN C P,WONG T Y,et al.Retinal microvasculature changes in amyloid-negative subcortical vascular cognitive impairment compared to amyloid-positive Alzheimer’s disease [J].J Neurol Sci,2019,396:94-101.
[22] MULDER J,ZILBERTER M,PASQUAR S J,ALPR A,SCHULTE G,FERREIRA S G,et al.Molecular reorganization of endocannabinoid signalling in Alzheimer’s disease [J].Brain,2011,134:1041-1060.
[23] MASUZZO A,DINET V,CAVANAGH C,MASCARELLI F,KRANTIC S.Amyloidosis in retinal neurodegenerative diseases[J].Front Neurol,2016,7:127.
[24] VAN H J,WESSELING P,Van DEN HEUVEL L P,De WAAL R M,VERBEEK M M.Heparan sulphate proteoglycans in Alzheimer’s disease and amyloid-related disorders[J].Lancet Neurol,2003,2(8):482-492.
[25] MANUELIDIS L.Infectious particles,stress,and induced prion amyloids:a unifying perspective [J].Virulence,2013,4(5):373-383.
[26] BULUT M,KURTULU F,GZKAYA O,EROL M K,CENGIZ A,AKIDAN M,et al.Evaluation of optical coherence tomography angiographic findings in Alzheimer’s type dementia [J].Br J Ophthalmol,2018,102(2):233-237.

相似文献/References:

[1]刘章 周琼.阿尔茨海默病、视神经及特殊蛋白三者关系的研究进展[J].眼科新进展,2012,32(12):000.
[2]陈娟,周琼.朊蛋白在阿尔茨海默病视网膜退行性病变中的作用研究进展[J].眼科新进展,2015,35(1):081.[doi:10.13389/j.cnki.rao.2015.0023]
 CHEN Juan,ZHOU Qiong.Recent advances in role of Prion protein in Alzheimer ’ s retinal degeneration disease[J].Recent Advances in Ophthalmology,2015,35(6):081.[doi:10.13389/j.cnki.rao.2015.0023]
[3]周琼,陈娟,徐婷婷. 细胞型朊蛋白在阿尔茨海默病和正常小鼠视网膜组织中的表达[J].眼科新进展,2015,35(7):601.[doi:10.13389/j.cnki.rao.2015.0163]
 ZHOU Qiong,CHEN Juan,XU Ting-Ting. Expression of prion protein in retinal tissue of Alzheimer ’ s disease and normal mouse[J].Recent Advances in Ophthalmology,2015,35(6):601.[doi:10.13389/j.cnki.rao.2015.0163]
[4]董志章,李娟,孙雪荣,等.强光照致TgAPPswePS1转基因鼠视网膜功能障碍和结构损伤[J].眼科新进展,2017,37(4):317.[doi:10.13389/j.cnki.rao.2017.0080]
 DONG Zhi-Zhang,LI Juan,SUN Xue-Rong,et al.Light exposure resulted in APPswe/PS1 transgenic mice retinal structural and functional disorder[J].Recent Advances in Ophthalmology,2017,37(6):317.[doi:10.13389/j.cnki.rao.2017.0080]
[5]李亭亭,刘芳,王方.年龄相关性黄斑变性与阿尔茨海默病的相关性[J].眼科新进展,2017,37(12):1189.[doi:10.13389/j.cnki.rao.2017.0300]
 LI Ting-Ting,LIU Fang,WANG Fang.Research progress on the relationship between age-related macular degeneration and Alzheimer’s disease[J].Recent Advances in Ophthalmology,2017,37(6):1189.[doi:10.13389/j.cnki.rao.2017.0300]
[6]刘宇航,毛小雪,牛媖,等.青光眼发病机制相关分子途径研究进展[J].眼科新进展,2021,41(3):290.[doi:10.13389/j.cnki.rao.2021.0061]
 LIU Yuhang,MAO Xiaoxue,NIU Ying,et al.Research progress on molecular pathways related to the pathogenesis of glaucoma[J].Recent Advances in Ophthalmology,2021,41(6):290.[doi:10.13389/j.cnki.rao.2021.0061]
[7]舒会叶,王怡欣,邵毅.超高分辨率OCT在眼科临床诊疗和基础研究中的应用[J].眼科新进展,2022,42(9):743.[doi:10.13389/j.cnki.rao.2022.0153]
 SHU Huiye,WANG Yixin,SHAO Yi.Application of ultrahigh-resolution optical coherence tomography in clinical diagnosis and treatment and basic research of ophthalmic diseases[J].Recent Advances in Ophthalmology,2022,42(6):743.[doi:10.13389/j.cnki.rao.2022.0153]

备注/Memo

备注/Memo:
国家自然科学基金项目(编号:81460092);江西省自然科学基金项目(编号:20114BAB205065)
更新日期/Last Update: 2020-06-05